Sartorius | SRT3 - Operating Expenses

Stock Price
209.70
Daily Change
-5.30 -2.47%
Monthly
-7.21%
Yearly
-15.27%
Q1 Forecast
203.68

Sartorius reported EUR693.1M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 43.82M 16.98M Mar/2025
Alaunos Therapeutics USD 1.19M 428K Sep/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Moderna USD 1.54B 259M Dec/2025
Organon & Co USD 906M 362M Sep/2025
Revvity USD 626.22M 25.62M Dec/2025
Sartorius EUR 693.1M 29.4M Sep/2025
Tectonic Therapeutic USD 21.89M 440K Sep/2025
Viatris USD 3.86B 335.7M Dec/2025
Xeris Pharmaceuticals USD 67.65M 590K Sep/2025